Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1993
11/09/1993US5260292 Topical treatment of acne with aminopenicillins
11/09/1993US5260282 Saliva substitute
11/09/1993US5260270 Applying to human nose to effect binding and concentrate odorants
11/09/1993US5260210 Blood-brain barrier model
11/09/1993US5260065 Blended lipid vesicles
11/09/1993US5260064 Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
11/09/1993CA2095499A1 Depot preparation
11/09/1993CA1324083C Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
11/09/1993CA1324081C Slow-release pharmaceutical agent
11/09/1993CA1324080C Bioadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents
11/09/1993CA1324078C Gel ointment base and gel ointment
11/09/1993CA1324077C Additives enhancing topical actions of therapeutic agents
11/08/1993CA2095588A1 Synthetic lipid a glycoconjugate antigens for use in vaccines
11/04/1993DE4225094A1 Compsn. for gene therapy, esp. of viral infections and tumours - comprises anti-sense DNA or RNA inserted into long terminal repeat or transposable element and e.g. virus envelope as carrier
11/03/1993EP0568500A1 Anti-idiotype monoclonal antibodies directed against anti-TNF antibodies
11/03/1993EP0568334A1 Collagen-containing sponges as drug delivery for proteins
11/03/1993EP0568307A1 Cosmetic composition containing alpha hydroxy carboxylic acids as preservatives
11/03/1993EP0568155A1 X-ray contrast formulations containing film-forming materials
11/03/1993EP0568026A2 Piroxicam tablets and production process thereof
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567528A1 Depot formulations
11/03/1993EP0567514A1 A METHOD AND A SYSTEM FOR ENHANCED $i(IN VIVO) CLEARANCE OF DIAGNOSTIC AND/OR THERAPEUTIC AGENTS BY EXTRACORPOREAL DEPLETION, AND THE USE OF SAID AGENTS FOR SAID PURPOSE
11/03/1993EP0551286A4 Soluble hirudin conjugates
11/03/1993EP0469064B1 Use of c-20 to c-26 aliphatic alcohols for the manufacture of a medicament for the treatment of viral infections
11/03/1993EP0374182B1 Biospecific polymers
11/03/1993EP0279862B1 Cytocidal antibody complex and process for its preparation
11/02/1993US5258538 For producing conjugates of organic moieties, such as fluorescent dyes and chromogens, and polymer supports or oligonucleotides
11/02/1993US5258499 Therapeutic or diagnostic agents encapsulated within liposomes
11/02/1993US5258453 Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
11/02/1993US5258375 Composition for the preparation of dosage-form active vitamins D3 containing polyvinylacetal diethylaminoacetate
11/02/1993US5258183 Medicine based on neutralized sulphur derivatives
11/02/1993US5258179 Protection of a food, cosmetic or pharmaceutical product against oxidation
11/02/1993US5258175 Administering acidic dextrin derivative
11/02/1993US5258041 Method of biomolecule attachment to hydrophobic surfaces
11/02/1993US5257766 Developed blank layout angle bracket
11/02/1993CA2094893A1 X-ray contrast compositions containing film-forming materials
11/02/1993CA1323837C Solid, rapidly disintegrating dosage form
11/02/1993CA1323836C Pharmaceutical compositions having good stability
11/02/1993CA1323835C Stabilised macrolide compositions
11/02/1993CA1323834C Controlled release dosage forms having a defined water content
11/02/1993CA1323831C Solubilization of salts of pyridine-2-thiol-1-oxide
10/1993
10/29/1993CA2095086A1 Piroxicam tablets and production process thereof
10/28/1993WO1993021232A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS
10/28/1993WO1993021229A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
10/28/1993WO1993021226A1 Cartilage matrix protein and methods for use
10/28/1993WO1993021193A1 Platinum complex and antineoplastic agent
10/28/1993WO1993021151A1 Substituted thioureas as bifunctional chelators
10/28/1993WO1993020857A1 Process for producing active agent complexes
10/28/1993WO1993020850A1 Pharmaceutical composition
10/28/1993WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993WO1993020838A1 Method and compositions for treatment of pyonecrotic processes
10/28/1993WO1993020834A1 Methods and compositions for oral delivery of therapeutic agents
10/28/1993WO1993020833A1 Pharmaceutical composition containing cyclosporin derivative
10/28/1993WO1993020808A1 Aminoguanidine spray drying process
10/28/1993WO1993020801A1 Liposome composition
10/28/1993WO1993020800A1 Composition for therapeutic or diagnostic use, process for its preparation and its use
10/28/1993WO1993013797A3 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera
10/28/1993WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993DE4213419A1 Topical medicaments contg. penetration enhancer - comprising glycerol tri:nitrate or glycerol mono- or di:nitrate conjugate
10/28/1993DE4213283A1 Verwendung von Copolymerisaten aus Carbonsäuren und langkettigen Verbindungen mit isolierten CC-Mehrfachverbindungen als Verdickungs- oder Dispergiermittel Use of copolymers of carboxylic acids and long-chain compounds with isolated CC multiple compounds as thickeners or dispersants
10/28/1993DE4213175A1 Compsns. for treating ketosis, esp. in ruminants, by oral admin. - contains glycerol as glucose biosynthesis precursor
10/28/1993CA2133739A1 Immunotoxins directed against c-erbb-2 (her-2/neu) related surface antigens
10/28/1993CA2118217A1 Platinum complex and antitumor agent
10/28/1993CA2117780A1 Cartillage matrix protein and methods for use
10/28/1993CA2117770A1 Substituted thioureas as bifunctional chelators
10/28/1993CA2117762A1 Pharmaceutical composition
10/28/1993CA2117749A1 Composition for therapeutic or diagnostic use, process for its preparation and its use
10/27/1993EP0567433A1 Orally-ingestible nutrition compositions having improved palatability
10/27/1993EP0567431A1 Apparatus for removing components from solutions
10/27/1993EP0567311A2 Hydrocolloid wound gel
10/27/1993EP0567234A1 Biopolymer composites
10/27/1993EP0567201A2 Vehicles for oral administration of a specific pharmaceutically active acid labile substance
10/27/1993EP0566630A1 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli
10/27/1993EP0548344A4 Collagen composites for controlled drug release
10/27/1993EP0425659B1 SUSTAINED RELEASE PHARMACEUTICAL PREPARATIONS HAVING pH CONTROLLED MEMBRANE COATINGS
10/27/1993EP0191824B1 Encapsulation of antineoplastic agents in liposomes
10/27/1993EP0190315B1 Dehydrated liposomes
10/26/1993US5256770 Oxidation resistant thrombomodulin analogs
10/26/1993US5256701 Disinfectant composition
10/26/1993US5256691 Oil-in-water type emulsified composition comprising non-steroidal antiphlogistic and analgesic drug
10/26/1993US5256652 Topical compositions and methods for treatment of male impotence
10/26/1993US5256647 Compositions comprising 1-substituted azacycloalkanes
10/26/1993US5256641 Covalent polar lipid-peptide conjugates for immunological targeting
10/26/1993US5256532 Methods, reagents and test kits for determination of subpopulations of biological entities
10/26/1993US5256413 Method and use for site-specific activation of substances
10/26/1993US5256396 Topical composition
10/26/1993US5256395 Drug delivery by administering a receptor binding assay having a dual preferential monoclonal antibody conjugating with predetermined haptens
10/26/1993CA1323578C Single-phase composition containing a perfluorinated oil and one or more surfactant(s), useful as an excipient for cosmetic and dermatologic formulations, as well as for biomedical applications
10/26/1993CA1323577C Emulsified external treatment composition containing diclofenac sodium
10/26/1993CA1323571C Pharmaceutical delivery device
10/26/1993CA1323566C Biodegradable polymeric drug delivery system with adjuvant activity
10/26/1993CA1323562C Dermal treatment of worm diseases in cats with praziquantel
10/25/1993CA2094665A1 Apparatus for removing components from solutions
10/24/1993CA2094658A1 Intracellular delivery of biochemical agents
10/22/1993WO1993020934A1 Stable aqueous suspension of liposome
10/22/1993CA2118487A1 Stable liposome aqueous suspension
10/20/1993EP0566535A1 Compositions comprising methanediphosphonic acids and ion-exchangers
10/20/1993EP0566438A1 Method for the preparation of D-maltose monoesters with a high 6-0'-ester content and their use in the cosmetic, dental-care, pharmaceuticals and food stuff fields
10/20/1993EP0566405A2 Aqueous gel retinoid dosage form
1 ... 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 ... 1712